We found 10 drugmaker programs for Multiple Sclerosis medicines and 4 charity funds (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Multiple Sclerosis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays for FDA-approved medications (plus travel for some funds).
Covers: Copays, premiums or other treatment costs.
Covers: Out-of-pocket costs for approved medications. Up to $8,000 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
AUBAGIO Co-Pay Program: commercially insured patients have a $0 co-payment for brand AUBAGIO, regardless of financial status. Not for Medicare, Medicaid, TRICARE.
One Start: eligible commercially insured patients may get AUBAGIO at no cost for up to 1 year while benefits are verified.
MS One to One works with insurers and doctors on benefit checks and prior authorizations; nurses offer support.
Other assistance may be available for people without insurance who meet eligibility requirements; an MS One to One Nurse can help.
Generic teriflunomide is available from multiple makers; these Sanofi programs apply only to brand AUBAGIO. The doctor must check the One Start box on the enrollment form. The page does not describe the uninsured program in detail and shows no phone number.
BRIUMVI Copay Assistance Program: eligible patients 18 and older with commercial insurance may pay as little as $0 copay per Briumvi treatment, up to an annual maximum of $20,000. Other eligibility requirements and full terms apply.
Infusion and administration costs: eligible commercially insured patients with out-of-pocket infusion costs may be covered up to $550 for the first infusion and up to $350 per infusion after that, through the same copay program.
BRIUMVI Patient Assistance Program for people who are uninsured or underinsured and meet certain financial eligibility criteria. Ask a BRIUMVI Patient Support case manager for details; income limits and what the program provides are not published on the page.
BRIUMVI Patient Support case managers answer questions and support the treatment journey. Call 1-833-BRIUMVI (1-833-274-8684), Monday to Friday, 8 AM to 8 PM ET. The page also points patients who do not qualify for TG programs to independent charitable foundations.
Phone is 1-833-BRIUMVI. Copay program is for commercially insured adults only. The page does not say what the Patient Assistance Program provides, so it is listed as 'other' rather than 'free-drug'. Full copay terms are at briumvicopayterms.com.
Commercially insured patients may pay as little as $0 for Copaxone; no financial qualifications. Medicare, Medicaid, TRICARE, VA and other government plans excluded.
Covers brand Copaxone only. Medicare patients are pointed to independent nonprofits. Generic glatiramer is also available.
Covers Gilenya 0.25 mg pediatric strength only: free to eligible patients who are uninsured or have government insurance and meet income limits.
Generic fingolimod is widely available. The foundation covers only the 0.25 mg pediatric capsule. The old Gilenya Go copay program is no longer online.
Co-Pay Plus: eligible patients with private insurance may pay as little as $0; combined annual limit up to $18,000.
If a commercially insured patient's coverage is denied pending prior authorization, up to 15 doses may be provided free until coverage is approved.
Dedicated Novartis Patient Support team helps with insurance paperwork, coverage questions, plan changes and ongoing support. Call 855-KESIMPTA, option 2 for financial and insurance help.
Novartis Patient Assistance Foundation may provide the medicine at no cost to patients who are uninsured or have government insurance and meet income guidelines.
Free drug is through the Novartis Patient Assistance Foundation (NPAF), a separate nonprofit; call 1-800-277-2254. Co-Pay Plus and bridge are not valid with Medicare, Medicaid, TRICARE, VA or other government coverage.
Novartis Patient Assistance Foundation may provide the medicine at no cost to patients who are uninsured or have government insurance and meet income guidelines.
MAYZENT is listed as supported by the Novartis Patient Assistance Foundation (see medications list). Ask the prescriber or Novartis about commercial copay help. No current Mayzent copay program is listed on official pages; the Novartis Patient Assistance Foundation still lists Mayzent for free medicine.
Eligible commercially insured patients may pay as little as $0 per treatment; up to $20,000 per calendar year for drug costs.
Help with infusion (administration) costs, as little as $0; up to $1,500 in year one and $1,000 each year after. Not in MA or RI.
Genentech Patient Foundation gives free OCREVUS to eligible patients, e.g. uninsured or not covered with household income under $150,000 (more for households over 4).
Patient Navigators explain insurance coverage, find financial help and work with your doctor and specialty pharmacy.
Covers OCREVUS and OCREVUS ZUNOVO. Copay programs exclude Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD and TRICARE. The free-drug program is run by the separate Genentech Patient Foundation; insured patients whose out-of-pocket maximum exceeds 7.5% of household income may also qualify. Hours: 6AM-5PM PT, Mon-Fri.
Biogen Copay Program may lower cost of brand-name Tecfidera to as little as $0 for eligible commercially insured patients; annual cap applies. Medicare, Medicaid, VA/DoD excluded.
Biogen Support Coordinators explain coverage and costs, help with prior authorization, and check options for government-insured, uninsured or underinsured patients.
Program covers brand-name Tecfidera only; generic dimethyl fumarate is widely available and not covered. For uninsured or underinsured patients, Biogen says it will research other possible financial help, but no Biogen free-drug program is described.
Biogen Copay Program may lower Tysabri drug cost for eligible commercially insured patients; annual cap applies. Medicare, Medicaid, VA/DoD and other federal plans excluded.
Infusion Copay Assistance Program pays up to $250 per infusion. Not for MA or RI residents or anyone on federal or state programs.
Biogen Support Coordinators explain coverage and costs, help with prior authorization, and look for options for government-insured, uninsured or underinsured patients.
No Biogen free-drug program is described on the page; for uninsured or underinsured patients, coordinators research other possible financial help.
Eligible commercially insured patients may pay as little as $0 a month for Zeposia; terms and conditions apply.
Reimbursement of medical costs for appointments or routine tests before starting Zeposia, for eligible commercially insured patients.
ZEPOSIA Bridge Program may help eligible commercially insured patients facing a coverage delay or denial.
Support Coordinator helps navigate insurance benefits, explore savings options and schedule routine tests.
For patients who have trouble affording Zeposia, Support Coordinators can help identify other options. The page does not describe a free-drug program.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 10 drugmaker programs for Multiple Sclerosis medicines and 4 charity funds, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Multiple Sclerosis, 0 charity funds on this page accept Medicare, and 3 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 4 funds listed for Multiple Sclerosis was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
Of the drugmaker programs for Multiple Sclerosis medicines, 5 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (The Assistance Fund, Good Days, HealthWell Foundation, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
